HSBC Holdings
CGEM icon

HSBC Holdings’s Cullinan Oncology CGEM Stock Holding History

HSBC Holdings’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-21,816
Closed -$221K – 3073
2023
Q4 		$221K Sell
21,816
-59
-0.3% -$523 ﹤0.01% 2424
2023
Q3 		$203K Buy
+21,875
New +$228K ﹤0.01% 2419
2023
Q2 		– Sell
-14,018
Closed -$147K – 2578
2023
Q1 		$147K Sell
14,018
-1,265
-8% -$13.9K ﹤0.01% 2447
2022
Q4 		$159K Hold
15,283
– – ﹤0.01% 2818
2022
Q3 		$199K Buy
+15,283
New +$206K ﹤0.01% 2632

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

HSBC Holdings's CGEM Position: Q1 2024 in Review

HSBC Holdings sold out of Cullinan Oncology (CGEM) in Q1 2024, closing a stake of 21,816 shares — an estimated $221K sold.

HSBC Holdings first reported a position in CGEM in Q3 2022 and held it in 5 quarters. The position peaked at $221K in Q4 2023. 113 funds tracked by Wall St. Rank hold CGEM as of Q1 2024.

  • HSBC Holdings reported no remaining Cullinan Oncology position as of Q1 2024 after selling out during the quarter.
  • HSBC Holdings sold 21,816 Cullinan Oncology shares in Q1 2024, an estimated $221K.
  • HSBC Holdings first reported a position in Cullinan Oncology in Q3 2022 and held it in 5 quarters.
  • HSBC Holdings's Cullinan Oncology position peaked at $221K in Q4 2023.
  • 113 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2024.

Based on HSBC Holdings's 13F filing for Q1 2024, filed 15 May 2024.